MARKER THERAPEUTICS, INC. (NASDAQ: MRKR) Files An 8-K Financial Statements and ExhibitsItem 9.01.
| ExhibitNo. | Description |
| 99.1 | Press release issued on November 27, 2018. |
Marker Therapeutics, Inc. ExhibitEX-99.1 2 tv507987_ex99-1.htm EXHIBIT 99.1 Exhibit 99.1 The Center for Cell and Gene Therapy at Baylor College of Medicine to Present at the 60th American Society of Hematology Annual Meeting –Three abstracts accepted,…To view the full exhibit click here